MSB 7.69% $1.19 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-992

  1. 1,445 Posts.
    lightbulb Created with Sketch. 3151
    " Because of the existence of other FDA priorities, we have not been able to reach a decision on the petition at this time. This interim response is provided in accordance with FDA regulations on citizen petitions (21 CFR 10.30(e)(2)(iv)). We will respond to your petition as soon as we have reached a decision on your request. "

    In the fullness of time...

    At the appropriate moment...

    After due consideration...

    Ha. Love it.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.